Dorothy Hanck to Sodium Channel Blockers
This is a "connection" page, showing publications Dorothy Hanck has written about Sodium Channel Blockers.
Connection Strength
1.442
-
Sodium channel molecular conformations and antiarrhythmic drug affinity. Trends Cardiovasc Med. 2010 Jan; 20(1):16-21.
Score: 0.365
-
Outward stabilization of the S4 segments in domains III and IV enhances lidocaine block of sodium channels. J Physiol. 2007 Jul 01; 582(Pt 1):317-34.
Score: 0.304
-
State-dependent mibefradil block of Na+ channels. Mol Pharmacol. 2004 12; 66(6):1652-61.
Score: 0.257
-
The Na channel voltage sensor associated with inactivation is localized to the external charged residues of domain IV, S4. Biophys J. 1999 Aug; 77(2):747-57.
Score: 0.177
-
Augmentation of recovery from inactivation by site-3 Na channel toxins. A single-channel and whole-cell study of persistent currents. J Gen Physiol. 1999 Feb; 113(2):333-46.
Score: 0.171
-
Charge at the lidocaine binding site residue Phe-1759 affects permeation in human cardiac voltage-gated sodium channels. J Physiol. 2007 Jun 01; 581(Pt 2):741-55.
Score: 0.075
-
Lidocaine alters activation gating of cardiac Na channels. Pflugers Arch. 2000 Apr; 439(6):814-21.
Score: 0.046
-
The role of exposed tryptophan residues in the activity of the cardiotonic polypeptide anthopleurin B. J Biol Chem. 1996 Sep 27; 271(39):23828-35.
Score: 0.036
-
Role for Pro-13 in directing high-affinity binding of anthopleurin B to the voltage-sensitive sodium channel. Biochemistry. 1996 Nov 12; 35(45):14157-64.
Score: 0.009